Baxter (formerly Hillrom)

Deerfield, Illinois, U.S. All United States companies → — Founded 1931

Biotech / Drug Discovery Healthcare Conglomerate Medical Device / Hardware

Critical Care Emergency Medicine Hospital Medicine

Patient Engagement & Education

Unknown — Undisclosed (over 6 funding rounds)

Website Claim this company

Products

Voalte

Baxter (formerly Hillrom)

Patient Engagement & Education

Voalte Platform is a software designed to facilitate clinical communication within healthcare settings. The software enables secure voice, alarm and text messaging among care teams using mobile devices and integrates with electronic medical records and hospital systems to streamline workflows. It supports real-time coordination of patient care, helps manage alerts and escalations from clinical systems, and offers features for directory management and role-based messaging.

Subscription-based, per-user or per-device fees

See all 1 product →

About Baxter (formerly Hillrom)

Baxter International Inc. is a multinational healthcare company that develops, manufactures, and commercializes a diverse portfolio of healthcare products and digital health solutions. For physicians, Baxter offers essential solutions across various care settings, including hospitals, physician offices, and homes. Their offerings span sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, and advanced surgical equipment. The company’s focus is on products to treat chronic and acute medical conditions, aiming to enhance surgical solutions, patient support systems, and overall patient safety and recovery.

Baxter’s strategic direction emphasizes integrating connected care assets and simplifying its portfolio through divestitures to focus on higher-growth areas in hospital solutions and connected care. This includes innovations in areas like infusion and medication safety, renal therapies, monitoring and diagnostics, care-environment systems, advanced surgery, clinical nutrition, and hospital pharmaceuticals. The company leverages its expertise in connectivity technology, digital health solutions, data visualization, and analytics to build a connected system that supports both patients and care teams, ultimately striving to increase workflow efficiencies and improve care outcomes.

Focus Areas

Medical devices pharmaceuticals biotechnology renal care infusion systems sterile solutions advanced surgery medication delivery digital health connected care technologies AI in supply chain management

Business Intelligence

Key Investors	The Vanguard Group, Inc., Dodge & Cox, Pzena Investment Management, LLC, BlackRock Institutional Trust Company, N.A., BlackRock Financial Management, Inc., State Street Investment Management (US), T. Rowe Price Associates, Inc., Geode Capital Management, L.L.C., Fidelity Management & Research Company LLC, Harris Associates L.P.
Partnerships	Oneview Healthcare, MUSC Health, MedTech Innovator, Amazon Web Services
Acquisitions	Hillrom, Seprafilm (from Sanofi), Claris Injectables (from Claris Lifesciences), Gambro, Baxa
Technology	Cloud-native, Industrial IoT platform, AI/ML systems for supply chain optimization, Xamarin.Forms for cross-platform mobile apps, ASP.NET with C# for backend and web portal
FDA Clearances	Multiple (specific number unknown, but includes Novum IQ syringe infusion pump with Dose IQ Safety Software, ST Set for CRRT, V-Link with VitalShield) cleared products (estimated)

What Physicians Need to Know

Medical Devices & Connected Care

Baxter (formerly Hillrom) offers a broad portfolio of medical devices, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and advanced equipment for surgical settings. They are focused on connected care solutions that integrate devices and data to enhance patient outcomes and workflow efficiencies.

Pharmaceuticals & Medication Delivery

Baxter provides foundational IV solutions, surgical sealants, and infusion pump platforms like Novum IQ. Their pharmaceutical segment manufactures specialty injectable drugs and inhaled anesthetics, with a focus on pre-mixed drugs to reduce dosing errors.

Digital Health & AI in Supply Chain

A growing focus for Baxter is digital health, which includes software that connects medical devices to Electronic Health Records (EHR) for real-time patient data monitoring. They are also transforming supply chain management through AI and machine learning integration, using an Industrial IoT platform to analyze real-time data from sensor-driven monitoring systems for anomaly detection and process optimization in manufacturing.

Advanced Surgery

Baxter offers technologies designed to enhance surgeons' techniques, increase efficiencies, and improve outcomes in advanced surgery.

Renal Care

Baxter has historically been a significant player in renal care, providing products and services for peritoneal dialysis, hemodialysis, and organ support therapies. However, they are in the process of divesting this segment, which will be known as Vantive.

Physician Tip

For physicians, Baxter's integrated approach to connected care means access to accurate, near real-time patient information directly within the EMR, which can improve clinical decision-making and patient safety by reducing manual data entry errors. Their smart beds with contact-free continuous monitoring can provide early detection of patient deterioration. The focus on digital health and connected devices aims to streamline workflows, allowing more time for patient care. Additionally, their commitment to integrating non-Hillrom products into their ecosystem demonstrates a broader vision for connected healthcare.

Baxter has established over 600 device interfaces and integrations with more than 150 EMR companies, ensuring broad compatibility. They offer solutions like Connex 360 Vital Signs Monitor and DeviceBridge for secure, automated transfer of patient vital signs to the EMR. Partnerships with companies like Imprivata enable fast, secure, 'No Click Access' to Baxter patient monitors, further streamlining clinician workflows and enhancing data security.

At a glance

Founded 1931

HQ Deerfield, Illinois, U.S. · United States

Team size 37,500 (as of December 31, 2025)

CEO Andrew Hider

Funding Unknown — Undisclosed (over 6 funding rounds)

FDA clearances Multiple (specific number unknown, but includes Novum IQ syringe infusion pump with Dose IQ Safety Software, ST Set for CRRT, V-Link with VitalShield) (estimated)

Products 1

Visit site

Products by Baxter (formerly Hillrom)

1 product in the directory

Voalte

Baxter (formerly Hillrom)

Patient Engagement & Education

Subscription-based, per-user or per-device fees

What the Web Says

Baxter (formerly Hillrom) receives mixed reviews regarding both its products and its employer practices. While some employees praise the benefits and work-life balance, others express concerns about management, job security, and company culture after the acquisition. Product reviews, particularly for hospital beds, highlight advanced features but also point to a decline in quality post-acquisition.

Overall: Mixed

Strengths

Good benefits and PTO.
Work-life balance is generally rated as decent.
Some products, like the Centrella hospital bed, offer advanced features for high-acuity patients.
Opportunities to learn new things.
Supportive team environments in some departments.
Commitment to ethics and compliance.

Limitations

Management issues, including favoritism, lack of transparency, and inexperience.
Decline in product quality, especially for former Hillrom products, since the acquisition.
Concerns about job security and frequent organizational changes/layoffs.
Long working hours and mandatory overtime in some production roles.
Perceived lack of growth opportunities and fair raises for promotions.
Financial struggles and a tough culture reported in some areas.

Based on reviews from: Indeed.com, Reddit, ETHealthworld, SonderCare

Last updated: 2026-07-26

Videos

News, demos, and interviews about Baxter (formerly Hillrom).

Loading videos...

Videos load interactively. If none appear, search YouTube for Baxter (formerly Hillrom) →

View all on YouTube

Press & Coverage

Respiratory Therapy

Baxter Completes Acquisition of Hillrom

Baxter International Inc. completed its acquisition of Hillrom for approximately $12.5 billion, including assumed debt, aiming to drive greater impact for patients, clinicians, and shareholders through complementary capabilities and digital health innovation.

2021-12

Fierce Biotech

Baxter's deal for smart hospital bed maker Hill-Rom swells to $10.5B

Baxter acquired Hill-Rom for approximately $10.5 billion in equity value, or $12.4 billion including debt, to combine complementary product portfolios and expand into connected care solutions globally.

2021-09

Baxter International Inc. (Press Release)

Baxter to Acquire Hillrom, Expanding Connected Care and Medical Innovation Globally

Baxter International Inc. announced a definitive agreement to acquire Hillrom for $156.00 per share in cash, totaling approximately $10.5 billion in equity value, to expand connected care and medical innovation globally.

2021-09

FDA

Baxter Issues Urgent Medical Device Correction Regarding Potential Radio Frequency Interference With Other Devices Near Beds Installed With WatchCare System

Baxter International Inc. issued an Urgent Medical Device Correction for the Hillrom WatchCare Incontinence Management System due to potential radio frequency interference with other medical devices.

2022-10

MarketScreener

Baxter Healthcare Corporation Faces Fda Enforcement Action for Hillrom Volara System P.Circuit Kit

The FDA issued an enforcement report for the Hillrom VOLARA System P. CIRCUIT KIT due to reports of air and medication leakage, which could lead to oxygen level drops and ineffective nebulization.

2026-07

MedTech Dive

Hillrom VP of connected care talks Baxter's $10.5B buy, digital health

Hillrom's VP of connected care discussed how Baxter's $10.5 billion acquisition validates Hillrom's digital health strategy and will expand connected care offerings across various healthcare settings.

2021-09

Baxter (Hillrom)

Pressure Ulcer Incidence & Progression - Hillrom

A study compared facility-acquired pressure ulcer incidence and progression in critically ill patients using two different support surfaces, highlighting the importance of support surface portfolios in acute care.

unknown

PubMed (Applied Ergonomics)

The effects of hospital bed features on physical stresses on caregivers when repositioning patients in bed - PubMed

Research investigated the impact of hospital bed features on physical stress for caregivers repositioning patients, finding that assistive features reduced stress but often still exceeded injury thresholds.

2020-09

Frequently Asked Questions

What is Baxter's current portfolio of medical devices and solutions, especially after the acquisition of Hillrom?

Baxter's portfolio now encompasses a broad range of medical devices and solutions, including Hillrom's connected care technologies, smart beds, and patient monitoring systems. This is integrated with Baxter's established offerings in renal care, infusion systems, sterile solutions, advanced surgery, and medication delivery. The combined entity aims to provide a more comprehensive suite of products for hospitals and healthcare systems.

How does Baxter (formerly Hillrom) address compliance and regulatory standards for its diverse product lines, particularly with new digital health and AI-driven solutions?

Baxter maintains a robust compliance framework that adheres to global regulatory standards such as FDA, EMA, and others relevant to medical devices, pharmaceuticals, and biotechnology. For new digital health and AI solutions, the company focuses on rigorous validation, data privacy (e.g., HIPAA), and cybersecurity protocols to ensure patient safety and data integrity.

What is Baxter's strategy for pricing its medical devices and solutions, and how does it offer value to healthcare providers in an evolving market?

Baxter's pricing strategy considers factors such as product innovation, clinical efficacy, and total cost of ownership for healthcare providers. The company aims to demonstrate value through improved patient outcomes, operational efficiencies, and integrated solutions that can reduce overall healthcare costs. They often engage in value-based contracting and provide flexible purchasing options.

What kind of technical support and clinical education does Baxter offer for its complex medical devices and integrated care platforms?

Baxter provides comprehensive technical support and clinical education programs for its medical devices and integrated care platforms. This includes on-site training, remote support, a dedicated customer service team, and online resources. They also offer specialized training for new product implementations and ongoing education to ensure optimal use and patient safety.

How is Baxter leveraging AI and connected care technologies to improve supply chain management and address potential disruptions for healthcare systems?

Baxter is integrating AI and connected care technologies to enhance supply chain visibility, predict demand fluctuations, and optimize inventory management. This includes using data analytics to proactively identify potential disruptions and implement mitigation strategies, aiming to ensure a more resilient and efficient supply chain for critical medical products.

What are Baxter's key partnerships in the biotechnology and digital health space, and how do these collaborations benefit healthcare providers?

Baxter actively pursues strategic partnerships in biotechnology and digital health to expand its capabilities and offer more integrated solutions. These collaborations often focus on developing new therapies, enhancing digital platforms for patient management, and integrating data for improved clinical decision-making, ultimately benefiting healthcare providers through innovation and expanded service offerings.

Given the recent acquisition and market changes, what is Baxter's long-term vision for company stability and continued innovation in the healthcare industry?

Baxter's long-term vision focuses on sustained innovation across its core therapeutic areas and expanding its digital health footprint. The company is committed to leveraging the combined strengths of Baxter and Hillrom to drive growth, enhance patient care, and maintain financial stability through strategic investments in R&D, market expansion, and operational efficiencies.

Related Companies

Suggest an Edit →